Биопсия предстательной железы под контролем магнитно-резонансной томографии

Standard

Биопсия предстательной железы под контролем магнитно-резонансной томографии. / Kuplevatskiy, V. I.; CherkashiN, M. A.; Roshchin, D. A.; Berezina, N. A.; Vorob'ev, N. A.

In: ВЕСТНИК РЕНТГЕНОЛОГИИ И РАДИОЛОГИИ, Vol. 97, No. 1, 01.01.2016, p. 48-55.

Research output: Contribution to journal › Review article › peer-review

Author

Kuplevatskiy, V. I. ; CherkashiN, M. A. ; Roshchin, D. A. ; Berezina, N. A. ; Vorob'ev, N. A. / Биопсия предстательной железы под контролем магнитно-резонансной томографии. In: ВЕСТНИК РЕНТГЕНОЛОГИИ И РАДИОЛОГИИ. 2016 ; Vol. 97, No. 1. pp. 48-55.

BibTeX

@article{64d042ce46f943029b26e9732ce4bbe9,

title = "Биопсия предстательной железы под контролем магнитно-резонансной томографии",

abstract = "Prostate cancer (PC) is one of the most important problems in modern oncology. According to statistical data, PC ranks second in the cancer morbidity structure in the Russian Federation and developed countries and its prevalence has been progressively increasing over the past decade. A need for early diagnosis and maximally accurate morphological verification of the diagnosis in difficult clinical cases (inconvenient tumor location for standard transrectal biopsy; gland scarring changes concurrent with prostatitis and hemorrhage; threshold values of prostate-specific antigen with unclear changes in its doubling per unit time; suspicion of biochemical recurrence or clinical tumor progression after special treatment) leads to revised diagnostic algorithms and clinically introduced new high-tech invasive diagnostic methods. This paper gives the first analysis of literature data on Russian practice using one of the new methods to verify prostate cancer (transrectal prostate cancer under magnetic resonance imaging (MRI) guidance). The have sought the 1995-2015 data in the MEDLINE and Pubmed.",

author = "Kuplevatskiy, {V. I.} and CherkashiN, {M. A.} and Roshchin, {D. A.} and Berezina, {N. A.} and Vorob'ev, {N. A.}",

year = "2016",

month = jan,

day = "1",

doi = "10.20862/0042-4676-2016-97-1-48-55",

language = "русский",

volume = "97",

pages = "48--55",

journal = "ВЕСТНИК РЕНТГЕНОЛОГИИ И РАДИОЛОГИИ",

issn = "0042-4676",

publisher = "Nauchnoe Obshchestvo Rentgenologov i Radiologov",

number = "1",

}

RIS

TY - JOUR

T1 - Биопсия предстательной железы под контролем магнитно-резонансной томографии

AU - Kuplevatskiy, V. I.

AU - CherkashiN, M. A.

AU - Roshchin, D. A.

AU - Berezina, N. A.

AU - Vorob'ev, N. A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Prostate cancer (PC) is one of the most important problems in modern oncology. According to statistical data, PC ranks second in the cancer morbidity structure in the Russian Federation and developed countries and its prevalence has been progressively increasing over the past decade. A need for early diagnosis and maximally accurate morphological verification of the diagnosis in difficult clinical cases (inconvenient tumor location for standard transrectal biopsy; gland scarring changes concurrent with prostatitis and hemorrhage; threshold values of prostate-specific antigen with unclear changes in its doubling per unit time; suspicion of biochemical recurrence or clinical tumor progression after special treatment) leads to revised diagnostic algorithms and clinically introduced new high-tech invasive diagnostic methods. This paper gives the first analysis of literature data on Russian practice using one of the new methods to verify prostate cancer (transrectal prostate cancer under magnetic resonance imaging (MRI) guidance). The have sought the 1995-2015 data in the MEDLINE and Pubmed.

AB - Prostate cancer (PC) is one of the most important problems in modern oncology. According to statistical data, PC ranks second in the cancer morbidity structure in the Russian Federation and developed countries and its prevalence has been progressively increasing over the past decade. A need for early diagnosis and maximally accurate morphological verification of the diagnosis in difficult clinical cases (inconvenient tumor location for standard transrectal biopsy; gland scarring changes concurrent with prostatitis and hemorrhage; threshold values of prostate-specific antigen with unclear changes in its doubling per unit time; suspicion of biochemical recurrence or clinical tumor progression after special treatment) leads to revised diagnostic algorithms and clinically introduced new high-tech invasive diagnostic methods. This paper gives the first analysis of literature data on Russian practice using one of the new methods to verify prostate cancer (transrectal prostate cancer under magnetic resonance imaging (MRI) guidance). The have sought the 1995-2015 data in the MEDLINE and Pubmed.

UR - http://www.scopus.com/inward/record.url?scp=84974725141&partnerID=8YFLogxK

U2 - 10.20862/0042-4676-2016-97-1-48-55

DO - 10.20862/0042-4676-2016-97-1-48-55

M3 - Обзорная статья

C2 - 27192773

AN - SCOPUS:84974725141

VL - 97

SP - 48

EP - 55

JO - ВЕСТНИК РЕНТГЕНОЛОГИИ И РАДИОЛОГИИ

JF - ВЕСТНИК РЕНТГЕНОЛОГИИ И РАДИОЛОГИИ

SN - 0042-4676

IS - 1

ER -

ID: 39055310